Upregulated Angiogenesis Is Incompetent to Rescue Dilated Cardiomyopathy Phenotype in Mice

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Regenerative Medicine

Background:

• Dilated cardiomyopathy (DCM) involves pathological cardiac remodeling and impaired contractility.
• Previous research suggests a link between DCM and reduced tissue angiogenesis.
• The role of enhanced angiogenesis in mitigating DCM progression remains unclear.

Purpose of the Study:

• To investigate if modulating cardiac angiogenesis can intervene in or rescue the DCM phenotype in a mouse model.
• To assess the impact of microRNA-210 (miR-210) overexpression on cardiac angiogenesis and DCM pathology.

Main Methods:

• Crossbreeding of a DCM mouse model (α-tropomyosin 54 mutant) with microRNA-210 transgenic mice (210-TG) to create TMx210 mice.
• Histopathological analysis to evaluate cardiac remodeling, including myocardial disarray, myofibrillar loss, and fibrosis.
• Assessment of angiogenic potential via blood vessel density and vascular endothelial growth factor-A (VEGF-A) expression.
• Echocardiographic evaluation of cardiac function.

Main Results:

• TMx210 and DCM mice exhibited increased heart weight to body weight ratio compared to WT and 210-TG mice.
• Histopathology confirmed pathological cardiac remodeling in both DCM and TMx210 mice.
• TMx210 and 210-TG mice showed enhanced angiogenic potential with higher blood vessel density and VEGF-A levels.
• Echocardiography revealed comparable cardiac dysfunction in DCM and TMx210 mice.

Conclusions:

• Upregulated angiogenesis mediated by miR-210 is insufficient to rescue the DCM phenotype in this mouse model.
• The findings suggest that while angiogenesis is important, it may not be the sole determinant in DCM progression or recovery.